Abstract
The physiochemical characteristics of nanoparticles affect their in vitro and in vivo performance significantly, such as diameter, surface chemistry, and shape. This paper disclosed the effect of enhanced permeation and retention (EPR) in mucus caused by nanoparticle shape on improving oral absorption. The spherical and rod-like mesoporous silica nanoparticles (MSNs) were used to evaluate shape effect of EPR in mucus. Fenofibrate was loaded in MSNs as model drug. The in vitro release of fenofibrate from MSNs was dependent on nanoparticle shapes, but faster than that of raw drug. The drug release slowed down with the increase of aspect ratio due to longer channels in rod-like MSNs with higher aspect ratio. However, in vivo study showed that the oral bioavailability of fenofibrate was the highest after loading in rod-like MSNs with aspect ratio of 5. The in vitro study of mechanisms revealed that superior mucus diffusion ability of rod-like MSNs with aspect ratio of 5 was conductive to higher bioavailability. Meanwhile, more rod-like MSNs with higher aspect ratio were able to diffuse into mucus and reside there compared to spherical and short counterparts, which demonstrated higher aspect ratio was beneficial to EPR effect of nanoparticles in mucus. This study provides significant implication in rational oral drug carrier design.
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12274-022-4601-2/MediaObjects/12274_2022_4601_Fig1_HTML.jpg)
Similar content being viewed by others
References
Zhang, Y. D.; Li, H. B.; Wang, Q.; Hao, X. Y.; Li, H. M.; Sun, H. Q.; Han, L.; Zhang, Z. R.; Zou, Q. M.; Sun, X. Rationally designed self-assembling nanoparticles to overcome mucus and epithelium transport barriers for oral vaccines against Helicobacter pylori. Adv. Funct. Mater. 2018, 28, 1802675.
Fan, W. W.; Xia, D. N.; Zhu, Q. L.; Li, X. X.; He, S. F.; Zhu, C. L.; Guo, S. Y.; Hovgaard, L.; Yang, M. S.; Gan, Y. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery. Biomaterials 2018, 151, 13–23.
García-Díaz, M.; Birch, D.; Wan, F.; Nielsen, H. M. The role of mucus as an invisible cloak to transepithelial drug delivery by nanoparticles. Adv. Drug Deliv. Rev. 2018, 124, 107–124.
Taherali, F.; Varum, F.; Basit, A. W. A slippery slope: On the origin, role and physiology of mucus. Adv. Drug Deliv. Rev. 2018, 124, 16–33.
Murgia, X.; Loretz, B.; Hartwig, O.; Hittinger, M.; Lehr, C. M. The role of mucus on drug transport and its potential to affect therapeutic outcomes. Adv. Drug Deliv. Rev. 2018, 124, 82–97.
Wu, L.; Shan, W.; Zhang, Z. R.; Huang, Y. Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties. Adv. Drug Deliv. Rev. 2018, 124, 150–163.
Suk, J. S.; Xu, Q. G.; Kim, N.; Hanes, J.; Ensign, L. M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 2016, 99, 28–51.
Bajka, B. H.; Rigby, N. M.; Cross, K. L.; Macierzanka, A.; Mackie, A. R. The influence of small intestinal mucus structure on particle transport ex vivo. Colloids Surf. B Biointerfaces 2015, 135, 73–80.
Li, D.; Zhuang, J.; He, H. S.; Jiang, S. F.; Banerjee, A.; Lu, Y.; Wu, W.; Mitragotri, S.; Gan, L.; Qi, J. P. Influence of particle geometry on gastrointestinal transit and absorption following oral administration. ACS Appl. Mater. Interfaces 2017, 9, 42492–42502.
Bao, C.; Liu, B.; Li, B.; Chai, J. J.; Zhang, L. W.; Jiao, L. L.; Li, D.; Yu, Z. Q.; Ren, F. Z.; Shi, X. H. et al. Enhanced transport of shape and rigidity-tuned α-lactalbumin nanotubes across intestinal mucus and cellular barriers. Nano Lett. 2020, 20, 1352–1361.
Banerjee, A.; Qi, J. P.; Gogoi, R.; Wong, J.; Mitragotri, S. Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J. Control. Release 2016, 238, 176–185.
Yu, M. R.; Wang, J. L.; Yang, Y. W.; Zhu, C. L.; Su, Q.; Guo, S. Y.; Sun, J. S.; Gan, Y.; Shi, X. H.; Gao, H. J. Rotation-facilitated rapid transport of nanorods in mucosal tissues. Nano Lett. 2016, 16, 7176–7182.
Sycuro, L. K.; Pincus, Z.; Gutierrez, K. D.; Biboy, J.; Stern, C. A.; Vollmer, W.; Salama, N. R. Peptidoglycan crosslinking relaxation promotes Helicobacter pylori’s helical shape and stomach colonization. Cell 2010, 141, 822–833.
Backhed, F.; Ley, R. E.; Sonnenburg, J. L.; Peterson, D. A.; Gordon, J. I. Host-bacterial mutualism in the human intestine. Science 2005, 307, 1915–1920.
Li, C.; Wang, J. C.; Wang, Y. G.; Gao, H. L.; Wei, G.; Huang, Y. Z.; Yu, H. J.; Gan, Y.; Wang, Y. J.; Mei, L. et al. Recent progress in drug delivery. Acta Pharm. Sin. B 2019, 9, 1145–1162.
Zhou, Y. X.; Quan, G. L.; Wu, Q. L.; Zhang, X. X.; Niu, B. Y.; Wu, B. Y.; Huang, Y.; Pan, X.; Wu, C. B. Mesoporous silica nanoparticles for drug and gene delivery. Acta Pharm. Sin. B 2018, 8, 165–177.
Maleki, A.; Kettiger, H.; Schoubben, A.; Rosenholm, J. M.; Ambrogi, V.; Hamidi, M. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs. J. Control. Release 2017, 262, 329–347.
Yildirim, A.; Bayindir, M. A porosity difference based selective dissolution strategy to prepare shape-tailored hollow mesoporous silica nanoparticles. J. Mater. Chem. A 2015, 3, 3839–3846.
Zhao, Y. T.; Wang, Y.; Ran, F.; Cui, Y.; Liu, C.; Zhao, Q. F.; Gao, Y. K.; Wang, D.; Wang, S. L. A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics. Sci. Rep. 2017, 7, 4131.
Hubatsch, I.; Ragnarsson, E. G. E.; Artursson, P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat. Protoc. 2007, 2, 2111–2119.
Friedl, H.; Dünnhaupt, S.; Hintzen, F.; Waldner, C.; Parikh, S.; Pearson, J. P.; Wilcox, M. D.; Bernkop-Schnürch, A. Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drug delivery systems. J. Pharm. Sci. 2013, 102, 4406–4413.
Zhang, X. X.; Li, F. F.; Guo, S. Y.; Chen, X.; Wang, X. L.; Li, J.; Gan, Y. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells. Biomaterials 2014, 35, 3650–3665.
Yu, T.; Malugin, A.; Ghandehari, H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 2011, 5, 5717–5728.
Slowing, I. I.; Trewyn, B. G.; Giri, S.; Lin, V. S. Y. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv. Funct. Mater. 2007, 17, 1225–1236.
You, Y. Y.; He, L. Z.; Ma, B.; Chen, T. F. High-drug-loading mesoporous silica nanorods with reduced toxicity for precise cancer therapy against nasopharyngeal carcinoma. Adv. Funct. Mater. 2017, 27, 1703313.
Wan, Y.; Zhao, D. Y. On the controllable soft-templating approach to mesoporous silicates. Chem. Rev. 2007, 107, 2821–2860.
Cong, V. T.; Gaus, K.; Tilley, R. D.; Gooding, J. J. Rod-shaped mesoporous silica nanoparticles for nanomedicine: Recent progress and perspectives. Expert Opin. Drug Deliv. 2018, 15, 881–892.
Pang, X. L.; Gao, J. N.; Tang, F. Q. Controlled preparation of rod-and top-like MCM-41 mesoporous silica through one-step route. J. Non-Cryst. Solids 2005, 351, 1705–1709.
Yang, Y. W.; Tian, F. L.; Nie, D.; Liu, Y.; Qian, K.; Yu, M. R.; Wang, A. H.; Zhang, Y. Q.; Shi, X. H.; Gan, Y. Rapid transport of germ-mimetic nanoparticles with dual conformational polyethylene glycol chains in biological tissues. Sci. Adv. 2020, 6, eaay9937.
Che, S. N.; Liu, Z.; Ohsuna, T.; Sakamoto, K.; Terasaki, O.; Tatsumi, T. Synthesis and characterization of chiral mesoporous silica. Nature 2004, 429, 281–284.
Qiu, P. P.; Ma, B.; Hung, C. T.; Li, W.; Zhao, D. Y. Spherical mesoporous materials from single to multilevel architectures. Acc. Chem. Res. 2019, 52, 2928–2938.
Zhang, L.; Qiao, S. Z.; Jin, Y. G.; Cheng, L. N.; Yan, Z. F.; Lu, G. Q. Hydrophobic functional group initiated helical mesostructured silica for controlled drug release. Adv. Funct. Mater. 2008, 18, 3834–3842.
Bremmell, K. E.; Prestidge, C. A. Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: Opportunities and challenges. Drug Dev. Ind. Pharm. 2019, 45, 349–358.
Bhujbal, S. V.; Mitra, B.; Jain, U.; Gong, Y. C.; Agrawal, A.; Karki, S.; Taylor, L. S.; Kumar, S.; Zhou, Q. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies. Acta Pharm. Sin. B 2021, 11, 2505–2536.
Sugano, K. Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect. Int. J. Pharm. 2010, 387, 103–109.
Wang, J. L.; Yang, Y. W.; Yu, M. R.; Hu, G. Q.; Gan, Y.; Gao, H. J.; Shi, X. H. Diffusion of rod-like nanoparticles in non-adhesive and adhesive porous polymeric gels. J. Mech. Phys. Solids 2018, 112, 431–457.
Löbenberg, R.; Amidon, G. L. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 2000, 50, 3–12.
Rosenberger, J.; Butler, J.; Dressman, J. A refined developability classification system. J. Pharm. Sci. 2018, 107, 2020–2032.
Yang, Y. Q.; Lv, Y. J.; Shen, C. Y.; Shi, T. T.; He, H. S.; Qi, J. P.; Dong, X. C.; Zhao, W. L.; Lu, Y.; Wu, W. In vivo dissolution of poorly water-soluble drugs:Proof of concept based on fluorescence bioimaging. Acta Pharm. Sin. B 2021, 11, 1056–1068.
Yu, T.; Greish, K.; McGill, L. D.; Ray, A.; Ghandehari, H. Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: Their vasculature effect and tolerance threshold. ACS Nano 2012, 6, 2289–2301.
Mohammadpour, R.; Yazdimamaghani, M.; Cheney, D. L.; Jedrzkiewicz, J.; Ghandehari, H. Subchronic toxicity of silica nanoparticles as a function of size and porosity. J. Control. Release 2019, 304, 216–232.
Mohammadpour, R.; Cheney, D. L.; Grunberger, J. W.; Yazdimamaghani, M.; Jedrzkiewicz, J.; Isaacson, K. J.; Dobrovolskaia, M. A.; Ghandehari, H. One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility. J. Control. Release 2020, 324, 471–481.
Fu, C. H.; Liu, T. L.; Li, L. L.; Liu, H. Y.; Chen, D.; Tang, F. Q. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials 2013, 34, 2565–2575.
Roy, B.; Mondal, A.; Bera, S. K.; Banerjee, A. Using Brownian motion to measure shape asymmetry in mesoscopic matter using optical tweezers. Soft Matter 2016, 12, 5077–5080.
Jurney, P.; Agarwal, R.; Singh, V.; Choi, D.; Roy, K.; Sreenivasan, S. V.; Shi, L. Unique size and shape-dependent uptake behaviors of non-spherical nanoparticles by endothelial cells due to a shearing flow. J. Control. Release 2017, 245, 170–176.
Acknowledgements
This work was financially supported by the National Natural Science Foundation of China (No. 81872826), the Science and Technology Commission of Shanghai Municipality (No. 18ZR1404100), and the Shanghai Pujiang Program (No. 18PJD001).
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
12274_2022_4601_MOESM1_ESM.pdf
Rod-like mesoporous silica nanoparticles facilitate oral drug delivery via enhanced permeation and retention effect in mucus
Rights and permissions
About this article
Cite this article
Liu, W., Zhang, L., Dong, Z. et al. Rod-like mesoporous silica nanoparticles facilitate oral drug delivery via enhanced permeation and retention effect in mucus. Nano Res. 15, 9243–9252 (2022). https://doi.org/10.1007/s12274-022-4601-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12274-022-4601-2